Triple Combination Therapy in High Risk Crohn's Disease (CD)

Vedolizumab Subcutaneous Long-Term Open-Label Extension Study

Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis

A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors (Study #1)

A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment

An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies